These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33360781)

  • 1. 4-Aminoquinoline compounds from the Spanish flu to COVID-19.
    Bazotte RB; Hirabara SM; Serdan TAD; Gritte RB; Souza-Siqueira T; Gorjao R; Masi LN; Antunes MM; Cruzat V; Pithon-Curi TC; Curi R
    Biomed Pharmacother; 2021 Mar; 135():111138. PubMed ID: 33360781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19.
    Al-Bari AA
    Curr Drug Targets; 2020; 21(16):1703-1721. PubMed ID: 32552642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
    Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarials as Antivirals for COVID-19: Believe it or Not!
    Saha BK; Bonnier A; Chong W
    Am J Med Sci; 2020 Dec; 360(6):618-630. PubMed ID: 32950177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
    Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Effects on Geriatric Population and Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccines in the Prevention and Treatment of COVID-19.
    Beeraka NM; Tulimilli SV; Greeshma MV; Dallavalasa S; Zhang Y; Xiao W; Fan R; Zhao D; Bettadapura ADS; Nataraj SM; Madhunapantula SV; Liu J
    Curr Med Chem; 2022; 29(20):3601-3621. PubMed ID: 35232337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.
    Lei ZN; Wu ZX; Dong S; Yang DH; Zhang L; Ke Z; Zou C; Chen ZS
    Pharmacol Ther; 2020 Dec; 216():107672. PubMed ID: 32910933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic.
    Tripathy S; Dassarma B; Roy S; Chabalala H; Matsabisa MG
    Int J Antimicrob Agents; 2020 Aug; 56(2):106028. PubMed ID: 32450198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review.
    Pereira BB
    J Toxicol Environ Health B Crit Rev; 2020 May; 23(4):177-181. PubMed ID: 32281481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Janus sword actions of chloroquine and hydroxychloroquine against COVID-19.
    Chen X; Geiger JD
    Cell Signal; 2020 Sep; 73():109706. PubMed ID: 32629149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
    Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.
    Naghipour S; Ghodousi M; Rahsepar S; Elyasi S
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1119-1133. PubMed ID: 32631083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
    Altulea D; Maassen S; Baranov MV; van den Bogaart G
    J Mol Cell Biol; 2021 Jul; 13(3):175-184. PubMed ID: 33693723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials.
    Patil VM; Singhal S; Masand N
    Life Sci; 2020 Aug; 254():117775. PubMed ID: 32418894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
    Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
    Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible mechanistic insights into iron homeostasis role of the action of 4-aminoquinolines (chloroquine/hydroxychloroquine) on COVID-19 (SARS-CoV-2) infection.
    Batiha GE; Shaheen HM; Al-Kuraishy HM; Teibo JO; Akinfe OA; Al-Garbee AI; Teibo TKA; Kabrah SM
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7565-7584. PubMed ID: 34919258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
    Uzunova K; Filipova E; Pavlova V; Vekov T
    Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Meo SA; Klonoff DC; Akram J
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4539-4547. PubMed ID: 32373993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
    Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.